These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8148464)

  • 41. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
    Gorelick KJ; Chmel H
    Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The role of bacterial endotoxins, receptors and cytokines in the pathogenesis of septic (endotoxin) shock].
    Lazarov S; Balutsov M; Ianev E
    Vutr Boles; 2000; 32(4):33-40. PubMed ID: 11688328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of endotoxins and bile acids in the pathogenesis of septic circulatory shock.
    Bertók L
    Acta Chir Hung; 1997; 36(1-4):33-6. PubMed ID: 9408277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The search for a magic bullet to fight sepsis.
    Bone RC
    JAMA; 1993 May; 269(17):2266-7. PubMed ID: 8474207
    [No Abstract]   [Full Text] [Related]  

  • 45. Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.
    Opal SM; Yu RL
    Drugs; 1998 Apr; 55(4):497-508. PubMed ID: 9561340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Septic shock: pathogenesis and treatment.
    Bansal T; Mohan A; Sharma SK
    J Assoc Physicians India; 1996 Jun; 44(6):407-14. PubMed ID: 9282562
    [No Abstract]   [Full Text] [Related]  

  • 47. [Septic shock in pregnancy].
    Bonomo A; Di Muccio L
    Minerva Ginecol; 1979; 31(7-8):523-9. PubMed ID: 481808
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of patients with septic shock by endotoxin antibodies].
    Fomsgaard A; Baek L
    Ugeskr Laeger; 1987 Aug; 149(34):2248-52. PubMed ID: 3451447
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunotherapy of sepsis.
    Evans TJ; Cohen J
    J Med Microbiol; 1993 Apr; 38(4):237-9. PubMed ID: 8474114
    [No Abstract]   [Full Text] [Related]  

  • 50. Monoclonal antibodies in sepsis and septic shock.
    Neilson D; Rao PN
    BMJ; 1992 Mar; 304(6827):639-40. PubMed ID: 1559102
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of gram-negative septic shock with an immunoglobulin.
    Werdan K; Pilz G
    Crit Care Med; 1992 Sep; 20(9):1364-5. PubMed ID: 1521458
    [No Abstract]   [Full Text] [Related]  

  • 52. [Biochemistry, molecular mechanism of action and biological effects of endotoxin].
    Burgmann H; Breyer S
    Wien Med Wochenschr; 1995; 145(9):211-7. PubMed ID: 7543712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Septomonab (Centoxin) in the treatment of gram-negative septicemia].
    Fomsgaard A
    Ugeskr Laeger; 1993 Apr; 155(14):1066-71. PubMed ID: 8497944
    [No Abstract]   [Full Text] [Related]  

  • 54. The development of a bedside algorithm capable of targeting anti-endotoxins to the responder subpopulations.
    Birmingham MC; Nix DE; Cumbo TJ; Collins DA; Wels PB; Schentag JJ
    Ther Drug Monit; 1993 Dec; 15(6):503-9. PubMed ID: 8122285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Endotoxin removal in septic shock].
    Matsuda K; Hirasawa H; Oda S; Shiga H; Nakanishi K; Nakamura M
    Nihon Geka Gakkai Zasshi; 2002 Dec; 103(12):880-6. PubMed ID: 12599928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Active mediators in the pathogenesis of septic shock and the importance of their neutralization in the treatment of patients].
    Bojić I
    Vojnosanit Pregl; 1996; 53(6):511-8. PubMed ID: 9229971
    [No Abstract]   [Full Text] [Related]  

  • 57. Pathogenic effects of endotoxin.
    Zivot JB; Hoffman WD
    New Horiz; 1995 May; 3(2):267-75. PubMed ID: 7583168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunotherapy in gram-negative bacterial infections.
    Lugowski C
    Acta Biochim Pol; 1995; 42(1):19-24. PubMed ID: 7653155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.
    Wortel CH; Dellinger RP
    Crit Care Med; 1993 Jan; 21(1):163-5. PubMed ID: 8420724
    [No Abstract]   [Full Text] [Related]  

  • 60. Anti-endotoxin immunotherapy in septic shock.
    Baumgartner JD; Glauser MP
    J Antimicrob Chemother; 1987 Apr; 19(4):551. PubMed ID: 3583974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.